Carbon-11-methionine PET imaging of choroidal melanoma and the time course after carbon ion beam radiotherapy

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1507-1514

  Tamura, Katsumi ^a   Yoshikawa, Kyosan ^a   Ishikawa, Hiroyuki ^a   Hasebe, Mitsuhiko ^a   Tsuji, Hiroshi ^a   Yanagi, Tsuyoshi ^a   Suzuki, Kazutoshi ^a   Kubo, Atsushi ^b   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Carbon ion beam therapy; Choroidal melanoma; MET PET

Indexed keywords

METHIONINE C 11;

ARTICLE; CANCER RADIOTHERAPY; CHOROID MELANOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; ION THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THERAPY EFFECT;

ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHOROID NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; METHIONINE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67650095300     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kaneko A: Incidence of malignant melanoma of the eye in Japan. Rinsyo Ganka 33: 941-947, 1979. (Pubitemid 9209379)
2. The Collaborative Ocular Melanoma Study Group: The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report No.18. Arch Ophthalmol 119: 969-982, 2001.
3. Wilson MW and Hungerford JL: Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106: 1579-1587, 1999. (Pubitemid 30214359)
4. Finger PT, Berson A, Nq T and Szechter A: Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study. Int J Radiat Oncol Biol Phys 54: 1438-1445, 2002. (Pubitemid 35380045)
5. Char DH, Quivey JM, Castro JR, Kroll S and Phillips T: Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. Ophthalmology 100: 1547-1554, 1993.
6. Damato B, Kacperek A, Chopra M, Campbell IR and Errington RD: Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 62: 1405-1411, 2005. (Pubitemid 40982062)
7. Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H, Matsufuji N, Futami Y, Fukuhara A, Hiraoka T, Furusawa Y, Ando K, Suzuki M, Soga. F and Kawachi K: Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Bio Phys 44: 201-210, 1999. (Pubitemid 29186209)
8. Graqoudas ES, Eqan KM, Saornil MA, Walsh SM, Albert DM and Seddon JM: The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology 100: 1555-1560, 1993. (Pubitemid 23292866)
9. Vikram R, Yeung HD, Macapinlac HA and Iyer RB: Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. Am J Roentgenol 191: 1545-1551, 2008.
10. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B and Riqo P: Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25: 1244-1247, 1998. (Pubitemid 28446049)
11. Rinne D, Baum RP, Hor G and Kaufmann R: Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography. Cancer 82: 1664-1671, 1998.
12. Wieder HA, Brucher BL, Zimmermann F, Becker K, Lordick F, Beer A, Schwaiqer M, Fink U, Siewert JR, Stein HJ and Weber WA: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22: 900-908, 2004. (Pubitemid 41103602)
13. Gritters LS, Francis IR, Zasadny KR and Wahl RL: Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 34: 1420-1427, 1993. (Pubitemid 23254334)
14. Stern PH and Hoffman RM: Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 20: 663-670, 1984. (Pubitemid 15183249)
15. Stern PH, Wallace CD and Hoffman RM: Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 119: 29-34, 1984. (Pubitemid 14138802)
16. Diala ES, Cheah MC, Rowitch D and Hoffman RM: Extent of DNA methylation in human tumor cells. J Natl Cancer Inst 71: 755-764, 1983. (Pubitemid 14232390)
17. Liteplo RG: Altered methionine metabolism in metastatic variants of a human melanoma cell line. Cancer Lett 44: 23-31, 1989. (Pubitemid 19050957)
18. Hoffman RM: Unbalanced transmethylation and the pertubation of the differentiated state leading to cancer. BioEssays 12: 163-166, 1990.
19. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishikawa K, Iwata R and Ido T: Differential diagnosis of lung tumor with positron emission tomography: a prospectiv study. J Nucl Med 31: 1927-1933, 1990.
20. Singhal T, Narayanan TK, Jain V, Mukherjee J and Mantil J: 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Inaging Biol 10: 1-18, 2007.
21. Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M and Joensuu H: Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 33: 691-695, 1992.
22. Lindholm P, Leskinen S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M and Joensuu H: Carbon-11 methionine PET imaging of malignant melanoma. J Nucl Med 36: 1806-1810, 1995.
23. Kubota K, Matsuzawa T, Takahashi T, Fujiwara T, Kinomura S, Ido T, Sato T, Kubota R, Tada M and Ishiwata K: Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J Nucl Med 30: 2012-2016, 1989. (Pubitemid 20024321)
24. Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T and Ido T: Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C] methionine, [6-3H] thymidine, and gallium-67. J Nucl Med 32: 2118-2123, 1991.
25. Garretson BR, Robertson DM and Earle JD: Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol 105: 1394-1397, 1987. (Pubitemid 17149934)
26. Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I and van Kaick G: Application of alpha-aminoiosbutyric acid, L-methionine, thymidine and 2-fluoro-2-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med 23: 55-60, 1996. (Pubitemid 26013616)
27. 11C] methionine. Int J Radiat Oncol Biol Phys 32: 787-794, 1995.
28. Huovinen R, Leskinen-Kallio S, Nagren K, Lehikoinen P, Routsalainen U and Teras M: Carbon-11-methionine and PET in evaluation of treatment response of breast cancer. Br J Cancer 67: 787-791, 1993. (Pubitemid 23101560)
29. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM and Albert DM: Histopathology of proton beam-irradiated vs. enucleated uveal melanomas. Arch Ophthalmol 110: 1112-1118, 1992.
30. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R and Ido T: Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31: 1927-1932, 1990.